Article Text

Download PDFPDF

Rapid increase in heated tobacco product (HTP) use from 2015 to 2019: from the Japan ‘Society and New Tobacco’ Internet Survey (JASTIS)
  1. Ai Hori1,
  2. Takahiro Tabuchi2,
  3. Naoki Kunugita3
  1. 1Department of Global Public Health, University of Tsukuba, Tsukuba, Ibaraki, Japan
  2. 2Cancer Control Center, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
  3. 3University of Occupational and Environmental Health Japan, Kitakyushu, Fukuoka, Japan
  1. Correspondence to Dr Ai Hori, Department of Global Public Health, University of Tsukuba, Tsukuba, Ibaraki 305-8577, Japan; ihori-sgy{at}umin.ac.jp

Statistics from Altmetric.com

Heated tobacco products (HTPs) were introduced in Japan in 2014 without sufficient scientific evidence about the associated health risks. Our previous report found substantial HTP use in Japan after 2016.1 This study aims to clarify how the prevalence of HTP use (IQOS, Ploom TECH and glo) has increased over the last 5 years in Japan using ongoing retrospective Japan ‘Society and New Tobacco’ Internet Survey (JASTIS) data.

Method

We calculated the prevalence of HTP use from 2015 to 2019 from the JASTIS dataset. At baseline in 2015, 8240 participants aged 15–69 years were randomly selected from a Japanese large internet search agency, Rakuten Research.2 Adjusted estimates using inverse probability weighting (IPW) obtained from a propensity score (calculated by logistic regression models using basic demographic and socioeconomic factors) were calculated to correct for the selectivity of internet-based samples, using a probability sample that is representative of the Japanese population from the Comprehensive Survey of Living Conditions of People on Health and Welfare.3 We further adjusted for non-response using IPW from the 2016 survey or after. Detailed methods are available elsewhere.4

Results

HTP use in Japan increased from 0.2% in 2015 to 11.3% in 2019, as estimated among participants aged 15–69 years (table 1). In 2019, HTP use prevalence was over 30% among current smokers with or without intention to quit (30.8% and 43.2 %, respectively). HTP use prevalence was more than 10% higher among men, participants in their 20s and 30s than other categories.

Table 1

Adjusted prevalence of current heated tobacco (HTP) use (use in previous 30 days) from 2015 to 2019 in Japan

According to product type, the most recent 2019 HTP use prevalence (95% CI) in Japan was estimated as follows: 5.8% (4.4%–7.6%) for IQOS, 6.1% (4.7%–7.8%) for Ploom TECH and 3.6% (2.6%–5.0%) for glo (online supplementary table 1).

Discussion

HTP use prevalence as estimated in the JASTIS study was 11.3% among the entire Japanese population and over 30% among baseline current cigarette smokers in 2019. Our 2017 report showed baseline current smokers with intention to quit were more likely to use HTPs.1 However, the updated estimate found use of HTPs had rapidly extended to current smokers, regardless of their intention to quit. The widespread availability of HTPs in Japan may encourage smokers of cigarettes to replace them with HTPs.

The widespread use of HTPs makes it difficult to create public health policies for a tobacco-free society. Following the revised Health Promotion Law,5 use of HTPs is allowed in specially designated rooms in restaurants where customers will also be able to eat and drink, from April 2020. Under the new law, the tobacco industry promotes HTPs on websites, in official stores, consumer electronics retailers and convenience stores.6 7 However, WHO advises policy-makers to ban HTP marketing and provide warning messages about HTPs as well as conventional cigarettes.8

Our study highlights the rapid spread of HTPs in Japan, especially among smokers, men and the younger population. The world highest prevalence of HTP use in Japan should be carefully monitored as it can forewarn other countries about the spread of HTPs.

Acknowledgments

We would like to thank Dr Julia Mortimer for English language editing.

References

View Abstract

Footnotes

  • Contributors TT had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.Study concept and design: all authors; acquisition of data: TT; analysis and interpretation of data: AH and TT; drafting of the manuscript: AH and TT; critical revision of the manuscript for important intellectual content: all authors; statistical analysis: AH and TT; and study supervision: NK.

  • Funding This work was supported by Health and Labour Sciences Research Grants (H26-junkankitou-ippan-023 and H29-tokubetsu-shitei-006) and Japan Society for the Promotion of Science (JSPS) KAKENHI Grants (JP18H03062).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval Ethics approval was obtained from the Research Ethics Committee of the Osaka International Cancer Institute (no.1412175183) and the National Institute of Public Health (NIPH-IBRA#12112).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.